Riskified and Appriss Retail Announce Pioneering Omnichannel Returns Fraud Prevention Solution
6.1.2025 15:21:00 CET | Business Wire | Press release
New partnership equips merchants with the ability to combat payments fraud and returns fraud and abuse across the entire customer journey
Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, and Appriss Retail, a top provider of return and claim authorization solutions, are excited to announce a groundbreaking partnership set to transform the retail landscape. This innovative collaboration aims to address the growing challenges of omnichannel fraud and abuse by integrating comprehensive data on consumer shopping patterns throughout the entire customer journey — both in physical stores and online. From checkout to post-fulfillment, this initiative will deliver real-time protection for retailers across all channels, ensuring a secure and seamless shopping experience for their customers.
A new era in omnichannel fraud prevention
In today’s rapidly evolving retail landscape, ensuring a seamless in-store and online customer experience while safeguarding against returns fraud is paramount. Through this partnership, Riskified and Appriss Retail can leverage their combined data and expertise to deliver a solution that significantly enhances merchants’ ability to prevent fraud and policy abuse consistently across all channels, whether online or in-store, from purchase to return. By joining forces, the two companies have one of the most comprehensive views of consumer behavior available to the retail industry, providing an unparalleled resource for combating retail fraud and abuse.
Riskified and Appriss Retail are committed to pioneering smart solutions that address the evolving challenges of modern retail. By utilizing cutting-edge technology and data-driven insights, these industry leaders are setting a new standard in fraud prevention.
"The return and claim landscape is evolving quickly, and fraud and abuse continue to be significant challenges for merchants, hitting over $100 billion in losses for retailers, as highlighted in ourannual returns report with Deloitte,” said Michael Osborne, CEO, Appriss Retail. “The challenge for merchants has been achieving a comprehensive omnichannel view, which, until this alliance with Riskified, did not exist. Together, we're equipping merchants with the tools to combat return and claim fraud across all channels while delivering the best possible experience for their consumers. By combining our individual strengths, Appriss Retail and Riskified have created an unparalleled omnichannel solution for merchants."
“As return and refund abuse continues to escalate, merchants today face the dual challenge of enhancing customer satisfaction while managing this significant risk. Our new partnership with Appriss Retail directly addresses this issue by offering, for the first time, true omnichannel fraud and policy abuse protection. This comprehensive offering seamlessly integrates online and offline channel data, streamlining workflows, reducing overhead costs, stemming losses, and providing a unique, unified view of customer interactions. We’re excited to leverage this partnership to deliver greater value and innovation to our clients,” said Eido Gal, CEO of Riskified.
Key benefits of the partnership:
- Omnichannel protection: By integrating Riskified and Appriss Retail capabilities, merchants can confidently prevent fraudulent returns and abusive claims regardless of whether they originated from an in-store or online purchase.
- 360-degree view: This joint solution will provide a unique, holistic understanding of a customer's identity and shopping patterns, stitching together consistent decisions across the customer journey and across all channels.
- Better customer experience: With an omnichannel view of the customer’s true identity, retailers can deliver superior experiences and robust policies with confidence, ultimately driving higher sales and maximizing profits.
According to new research from Opinium and Cebr, commissioned by Riskified, returns, refunds, and exchanges constitute a staggering $394 billion expense for retailers in key ecommerce markets, and only three in 10 merchants have implemented a strategy to prevent fraudulent returns and refunds. To learn more about how retailers and their customers are impacted by policy abuse, download Riskified’s Returns, refunds, exchanges: Global insights and policy playbook.
Additional details on the partnership are available at - www.riskified.com/lp/partner/appriss-retail/
About Riskified
Riskified (NYSE:RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, Riskified’s AI-powered fraud and risk intelligence platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Riskified was named to CNBC's World’s Top Fintech Companies in 2024. Learn more at riskified.com.
About Appriss Retail
Appriss Retail provides retailers with protection against fraud and abuse for every transaction, no matter where it happens. With more than 20 years of retail data science expertise and experience, we’ve built a collective, omnichannel intelligence platform that is trusted by over 60 of the top 100 U.S. retailers, covering one-third of all U.S. omnichannel sales across 150,000 locations. Globally, Appriss Retail reaches 45 countries across six continents. The company provides relevant, actionable, and profitable collective intelligence to retail operations, finance, marketing, and loss prevention teams. Appriss Retail’s performance-improvement solutions yield measurable results with a significant return on investment. For more information about Appriss Retail, visit apprissretail.com or our LinkedIn page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106409952/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom